 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper   
127th MAINE LEGISLATURE  
 
SECOND REGULAR SESSION -2016  
 
Legislative Document  No. 1646  
S.P. 671  In Senate, March 10, 2016  
 
 
An Act To Prevent Opiate Abuse by Strengthening the Controlled 
Substances Prescription Monitoring Program  
 
 
 
 
Reference to the Committee on Health and Human Services suggested and ordered printed.  
 
 
  
 HEATHER J.R. PRIEST  
 Secretary of the Senate  
 
Presented by Senator CUSHING of Penobscot.  (GOVERNOR'S BILL)  
Cosponsored by Representative McCABE of Skowhegan and  
Senators: HASKELL of Cumberland, MASON of Androscoggin, McCORMICK of Kennebec, 
Representatives: ESPLING of New Gloucester, HEAD of Bethel, PETERSON of Rumford, 
SANDERSON of Chelsea, VACHON of Scarborough.  
 
 

 
 Page 1 - 127LR2717(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA §7249, sub -§4, as enacted by PL 2003, c. 483, §1, is amended 2 
to read:  3 
4.  Immunity from liability.   A dispenser or prescriber  is immune from liability for 4 
disclosure of informat ion if the disclosure was made pursuant to and in accordance with 5 
this chapter.  6 
Sec. 2.  22 MRSA §7251, sub -§1, as amended by PL 2011, c. 657, Pt. AA, §70, is 7 
further amended to read:  8 
1.  Failure to submit information.   A dispenser who knowingly fails to s ubmit 9 
prescription monitoring information to the department as required by this chapter 10 
commits a civil violation for which a fine of $250 per incident, not to exceed $5,000 per 11 
calendar year, may be adjudged and  is subject to discipline by the Maine Board  of 12 
Pharmacy pursuant to Title 32, chapter 117, subchapter 4 or by the applicable 13 
professional licensing entity.  14 
Sec. 3.  22 MRSA §7253 is enacted to read:  15 
§7253.  Prescribers and dispensers required to check prescription monitoring 16 
information  17 
1.  Prescri bers.  Upon initial prescription of a benzodiazepine or an opioid to a 18 
person and every 90 days for as long as the prescription is renewed, a prescriber shall 19 
check prescription monitoring information for records related to that person.  20 
2.  Dispensers.  Prior to dispensing a benzodiazepine or an opioid to a person, a 21 
dispenser shall check prescription monitoring information for records related to that 22 
person.  A dispenser shall notify the program and withhold a prescription until the 23 
dispenser is able to co ntact the prescriber of that prescription if the dispenser has reason 24 
to believe that that prescription is fraudulent or duplicative.  25 
3.  Violation.  A person who violates this section commits a civil violation for which 26 
a fine of $250 per incident, not to  exceed $5,000 per calendar year, may be adjudged.  27 
4.  Rulemaking.   Notwithstanding section 7252, the department may adopt routine 28 
technical rules as defined in Title 5, chapter 375, subchapter 2 -A to implement this 29 
section.  30 
Sec. 4.  32 MRSA §1062 -B is ena cted to read:  31 
§1062 -B.  Requirements regarding prescription of opioid pain medication  32 
1.  Limits on opioid prescribing.  An individual licensed under this chapter and 33 
whose scope of practice includes prescribing medication:  34 
A.  Must successfully complete a  training course by December 31, 2017 and every 5 35 
years thereafter on the prescription of opioid pain medication that has been approved 36 
 
 Page 2 - 127LR2717(01) -1 
 by the Department of Health and Human Services as a condition of prescribing opioid 1 
pain medications.  The department sh all make publicly available a list of approved 2 
opioid prescription training courses;  3 
B.  May not prescribe in excess of 100 morphine milligram equivalents of an opioid 4 
pain medication per day to any one patient;  5 
C.  May not prescribe within a 15 -day period  more than a 15 -day supply of an opioid 6 
pain medication to a patient under treatment for chronic pain;  7 
D.  May not prescribe within a 3 -day period more than a 3 -day supply of an opioid 8 
pain medication to a patient under treatment for acute pain; and  9 
E.  Beginning January 1, 2018, may only prescribe opioid pain medications 10 
electronically.  11 
2.  Penalties.  An individual who violates this section commits a civil violation for 12 
which a fine of $250 per violation, not to exceed $5,000 per calendar year, may be 13 
adjudged.  The Department of Health and Human Services is responsible for the 14 
enforcement of this section.  15 
Sec. 5.  32 MRSA §1077, sub -§2, ¶H, as amended by PL 1993, c. 600, Pt. A, 16 
§62, is further amended to read:  17 
H.  A violation of this chapter or a rule ado pted by the board; or 18 
Sec. 6.  32 MRSA §1077, sub -§2, ¶I, as enacted by PL 1983, c. 378, §7, is 19 
amended to read:  20 
I.  Engaging in false, misleading or deceptive advertising .; or 21 
Sec. 7.  32 MRSA §1077, sub -§2, ¶J is enacted to read:  22 
J.  Failure to comply wi th the requirements of Title 22, section 7251, subsection 1 or 23 
Title 22, section 7253.  24 
Sec. 8.  32 MRSA §2105 -A, sub -§2, ¶H, as amended by PL 1993, c. 600, Pt. A, 25 
§116, is further amended to read:  26 
H.  A violation of this chapter or a rule adopted by the bo ard; or 27 
Sec. 9.  32 MRSA §2105 -A, sub -§2, ¶I, as enacted by PL 1983, c. 378, §21, is 28 
further amended to read:  29 
I.  Engaging in false, misleading or deceptive advertising .; or 30 
Sec. 10.  32 MRSA §2105 -A, sub -§2, ¶J is enacted to read:  31 
J.  Failure to comply wi th the requirements of Title 22, section 7251, subsection 1 or 32 
Title 22, section 7253.  33 
Sec. 11.  32 MRSA §2210 is enacted to read:  34 
 
 Page 3 - 127LR2717(01) -1 
 §2210.  Requirements regarding prescription of opioid pain medication  1 
1.  Limits on opioid prescribing.  An individual licens ed under this subchapter:  2 
A.  Must successfully complete a training course by December 31, 2017 and every 5 3 
years thereafter on the prescription of opioid pain medication that has been approved 4 
by the Department of Health and Human Services as a condition of prescribing opioid 5 
pain medications.  The department shall make publicly available a list of approved 6 
opioid prescription training courses;  7 
B.  May not prescribe in excess of 100 morphine milligram equivalents of an opioid 8 
pain medication per day to any  one patient;  9 
C.  May not prescribe within a 15 -day period more than a 15 -day supply of an opioid 10 
pain medication to a patient under treatment for chronic pain;  11 
D.  May not prescribe within a 3 -day period more than a 3 -day supply of an opioid 12 
pain medicati on to a patient under treatment for acute pain; and  13 
E.  Beginning January 1, 2018, may only prescribe opioid pain medications 14 
electronically.  15 
2.  Penalties.  An individual who violates this section commits a civil violation for 16 
which a fine of $250 per vio lation, not to exceed $5,000 per calendar year, may be 17 
adjudged.  The Department of Health and Human Services is responsible for the 18 
enforcement of this section.  19 
Sec. 12.  32 MRSA §2591 -A, sub -§2, ¶M, as amended by PL 1997, c. 680, Pt. B, 20 
§6, is further am ended to read:  21 
M.  Failure to comply with the requirements of Title 24, section 2905 -A; or 22 
Sec. 13.  32 MRSA §2591 -A, sub -§2, ¶N, as enacted by PL 1997, c. 680, Pt. B, 23 
§7, is amended to read:  24 
N.  Revocation, suspension or restriction of a license to practi ce medicine or other 25 
disciplinary action; denial of an application for a license; or surrender of a license to 26 
practice medicine following the institution of disciplinary action by another state or a 27 
territory of the United States or a foreign country if t he conduct resulting in the 28 
disciplinary or other action involving the license would, if committed in this State, 29 
constitute grounds for discipline under the laws or rules of this State .; or 30 
Sec. 14.  32 MRSA §2591 -A, sub -§2, ¶O is enacted to read:  31 
O.  Failure to comply with the requirements of Title 22, section 7251, subsection 1 or 32 
Title 22, section 7253.  33 
Sec. 15.  32 MRSA §2600 -C is enacted to read:  34 
§2600 -C.  Requirements regarding prescription of opioid pain medication  35 
1.  Limits on opioid prescribing.  An individual licensed under this chapter:  36 
 
 Page 4 - 127LR2717(01) -1 
 A.  Must successfully complete a training course by December 31, 2017 and every 5 1 
years thereafter on the prescription of opioid pain medication that has been approved 2 
by the Department of Health and Human Servic es as a condition of prescribing opioid 3 
pain medications.  The department shall make publicly available a list of approved 4 
opioid prescription training courses;  5 
B.  May not prescribe in excess of 100 morphine milligram equivalents of an opioid 6 
pain medicat ion per day to any one patient;  7 
C.  May not prescribe within a 15 -day period more than a 15 -day supply of an opioid 8 
pain medication to a patient under treatment for chronic pain;  9 
D.  May not prescribe within a 3 -day period more than a 3 -day supply of an op ioid 10 
pain medication to a patient under treatment for acute pain; and  11 
E.  Beginning January 1, 2018, may only prescribe opioid pain medications 12 
electronically.  13 
2.  Penalties.  An individual who violates this section commits a civil violation for 14 
which a fi ne of $250 per violation, not to exceed $5,000 per calendar year, may be 15 
adjudged.  The Department of Health and Human Services is responsible for the 16 
enforcement of this section.  17 
Sec. 16.  32 MRSA §3282 -A, sub -§2, ¶¶Q and R, as enacted by PL 2013, c. 18 
355, §12, are amended to read:  19 
Q.  Failure to produce upon request of the board any documents in the licensee's 20 
possession or under the licensee's control concerning a pending complaint or 21 
proceeding or any matter under investigation by the board, unless other wise 22 
prohibited by state or federal law; or 23 
R.  Failure to timely respond to a complaint notification sent by the board .; or 24 
Sec. 17.  32 MRSA §3282 -A, sub -§2, ¶S is enacted to read:  25 
S.  Failure to comply with the requirements of Title 22, section 7251, su bsection 1 or 26 
Title 22, section 7253.  27 
Sec. 18.  32 MRSA §3300 -F is enacted to read:  28 
§3300 -F.  Requirements regarding prescription of opioid pain medication  29 
1.  Limits on opioid prescribing.  An individual licensed under this chapter:  30 
A.  Must successfully complete a training course by December 31, 2017 and every 5 31 
years thereafter on the prescription of opioid pain medication that has been approved 32 
by the Department of Health and Human Services as a condition of prescribing opioid 33 
pain medications.  The dep artment shall make publicly available a list of approved 34 
opioid prescription training courses;  35 
B.  May not prescribe in excess of 100 morphine milligram equivalents of an opioid 36 
pain medication per day to any one patient;  37 
 
 Page 5 - 127LR2717(01) -1 
 C.  May not prescribe within a 15 -day period more than a 15 -day supply of an opioid 1 
pain medication to a patient under treatment for chronic pain;  2 
D.  May not prescribe within a 3 -day period more than a 3 -day supply of an opioid 3 
pain medication to a patient under treatment for acute pain; and 4 
E.  Beginning January 1, 2018, may only prescribe opioid pain medications 5 
electronically.  6 
2.  Penalties.  An individual who violates this section commits a civil violation for 7 
which a fine of $250 per violation, not to exceed $5,000 per calendar year, may be 8 
adjudged.  The Department of Health and Human Services is responsible for the 9 
enforcement of this section.  10 
Sec. 19.  32 MRSA §3656, sub -§§3 and 4, as enacted by PL 2007, c. 402, Pt. P, 11 
§14, are amended to read:  12 
3.  False advertising.  Engaging in f alse, misleading or deceptive advertising; or 13 
4.  Unlawful prescription of controlled substance.  Prescribing narcotic or hypnotic 14 
or other drugs listed as controlled substances by the federal Drug Enforcement 15 
Administration for other than accepted therape utic purposes .; or 16 
Sec. 20.  32 MRSA §3656, sub -§5 is enacted to read:  17 
5.  Controlled Substances Prescription Monitoring Program.   Failure to comply 18 
with the requirements of Title 22, section 7251, subsection 1 or Title 22, section 7253.  19 
Sec. 21.  32 MRSA §3657 is enacted to read:  20 
§3657.  Requirements regarding prescription of opioid pain medication  21 
1.  Limits on opioid prescribing.  An individual licensed under this chapter:  22 
A.  Must successfully complete a training course by December 31, 2017 and every 5 23 
years thereafter on the prescription of opioid pain medication that has been approved 24 
by the Department of Health and Human Services as a condition of prescribing opioid 25 
pain medications.  The department shall make publicly available a list of approved 26 
opioid prescription training courses;  27 
B.  May not prescribe in excess of 100 morphine milligram equivalents of an opioid 28 
pain medication per day to any one patient;  29 
C.  May not prescribe within a 15 -day period more than a 15 -day supply of an opioid 30 
pain medic ation to a patient under treatment for chronic pain;  31 
D.  May not prescribe within a 3 -day period more than a 3 -day supply of an opioid 32 
pain medication to a patient under treatment for acute pain; and  33 
E.  Beginning January 1, 2018, may only prescribe opioid  pain medications 34 
electronically.  35 
 
 Page 6 - 127LR2717(01) -1 
 2.  Penalties.  An individual who violates this section commits a civil violation for 1 
which a fine of $250 per violation, not to exceed $5,000 per calendar year, may be 2 
adjudged.  The Department of Health and Human Service s is responsible for the 3 
enforcement of this section.  4 
SUMMARY  5 
This bill makes the following changes to the laws governing the Controlled 6 
Substances Prescription Monitoring Program and the prescribing and dispensing of 7 
opioids and other drugs.  8 
1.  It provi des to a prescriber immunity from liability for disclosure of information to 9 
the Controlled Substances Prescription Monitoring Program.  10 
2.  It provides that upon initial prescription of a benzodiazepine or an opioid to a 11 
person and every 90 days for as lon g as the prescription is renewed, a prescriber must 12 
check prescription monitoring information maintained by the Controlled Substances 13 
Prescription Monitoring Program for records related to that person.  A prescriber who 14 
violates this provision is subject t o a fine of $250 per incident, not to exceed $5,000 per 15 
calendar year.  16 
3.  It provides that prior to dispensing a benzodiazepine or an opioid to a person, a 17 
dispenser must check prescription monitoring information maintained by the Controlled 18 
Substances Pr escription Monitoring Program for records related to that person.  A 19 
dispenser must notify the program and withhold a prescription until the dispenser is able 20 
to contact the prescriber of that prescription if the dispenser has reason to believe that that 21 
prescription is fraudulent or duplicative.  A dispenser who violates these provisions is 22 
subject to a fine of $250 per incident, not to exceed $5,000 per calendar year.  23 
4.  It provides that the failure of a health care provider who is a prescriber or 24 
dispen ser to check prescription monitoring information or to submit prescription 25 
monitoring information to the Department of Health and Human Services as required by 26 
law is grounds for discipline of that health care provider.  27 
5.  It requires that by December 31,  2017 and every 5 years thereafter a health care 28 
provider who is a prescriber must successfully complete a training course on the 29 
prescription of opioid pain medication that has been approved by the Department of 30 
Health and Human Services as a condition of  prescribing opioid pain medications.  31 
6.  It sets limits on the amount of opioid pain medication that may be prescribed to a 32 
patient.  33 
7.  It provides that beginning January 1, 2018, opioid pain medication may only be 34 
prescribed electronically.  35 
 
